These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 8356071)

  • 21. The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.
    Andoniou CE; Lill NL; Thien CB; Lupher ML; Ota S; Bowtell DD; Scaife RM; Langdon WY; Band H
    Mol Cell Biol; 2000 Feb; 20(3):851-67. PubMed ID: 10629042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cloning of a cDNA encoding a phosphoprotein, Efs, which contains a Src homology 3 domain and associates with Fyn.
    Ishino M; Ohba T; Sasaki H; Sasaki T
    Oncogene; 1995 Dec; 11(11):2331-8. PubMed ID: 8570184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.
    Muthuswamy SK; Muller WJ
    Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development.
    Arnaud L; Ballif BA; Förster E; Cooper JA
    Curr Biol; 2003 Jan; 13(1):9-17. PubMed ID: 12526739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-derived growth factor activates porcine thecal cell phosphatidylinositol-3-kinase-Akt/PKB and ras-extracellular signal-regulated kinase-1/2 kinase signaling pathways via the platelet-derived growth factor-beta receptor.
    Taylor CC
    Endocrinology; 2000 Apr; 141(4):1545-53. PubMed ID: 10746662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-derived growth factor-mediated signaling through the Shb adaptor protein: effects on cytoskeletal organization.
    Hooshmand-Rad R; Lu L; Heldin CH; Claesson-Welsh L; Welsh M
    Exp Cell Res; 2000 Jun; 257(2):245-54. PubMed ID: 10837138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No requirement for src family kinases for PDGF signaling in fibroblasts expressing SV40 large T antigen.
    Broome MA; Courtneidge SA
    Oncogene; 2000 Jun; 19(24):2867-9. PubMed ID: 10851090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palmitoylation of multiple Src-family kinases at a homologous N-terminal motif.
    Koegl M; Zlatkine P; Ley SC; Courtneidge SA; Magee AI
    Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):749-53. PubMed ID: 7980442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The p60c-src family of protein-tyrosine kinases: structure, regulation, and function.
    Brickell PM
    Crit Rev Oncog; 1992; 3(4):401-46. PubMed ID: 1384720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of src-related tyrosine kinases by IL-3.
    Anderson SM; Jorgensen B
    J Immunol; 1995 Aug; 155(4):1660-70. PubMed ID: 7636226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of Src-family protein tyrosine kinases and phosphatidylinositol 3-kinase in 3T3-L1 mouse preadipocytes by interleukin-11.
    Fuhrer DK; Yang YC
    Exp Hematol; 1996 Feb; 24(2):195-203. PubMed ID: 8641341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of platelet-derived growth factor-induced Ras signaling by poliovirus receptor Necl-5 and negative growth regulator Sprouty2.
    Kajita M; Ikeda W; Tamaru Y; Takai Y
    Genes Cells; 2007 Mar; 12(3):345-57. PubMed ID: 17352739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of Src family kinase activity by the G protein-coupled thrombin receptor in growth-responsive fibroblasts.
    Chen YH; Pouysségur J; Courtneidge SA; Van Obberghen-Schilling E
    J Biol Chem; 1994 Nov; 269(44):27372-7. PubMed ID: 7525555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of JAK-STAT pathway is required for platelet-derived growth factor-induced proliferation of pancreatic stellate cells.
    Masamune A; Satoh M; Kikuta K; Suzuki N; Shimosegawa T
    World J Gastroenterol; 2005 Jun; 11(22):3385-91. PubMed ID: 15948243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ret-mediated mitogenesis requires Src kinase activity.
    Melillo RM; Barone MV; Lupoli G; Cirafici AM; Carlomagno F; Visconti R; Matoskova B; Di Fiore PP; Vecchio G; Fusco A; Santoro M
    Cancer Res; 1999 Mar; 59(5):1120-6. PubMed ID: 10070972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fyn is required for oxidative- and hyperosmotic-stress-induced tyrosine phosphorylation of caveolin-1.
    Sanguinetti AR; Cao H; Corley Mastick C
    Biochem J; 2003 Nov; 376(Pt 1):159-68. PubMed ID: 12921535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyomavirus middle-T antigen associates with the kinase domain of Src-related tyrosine kinases.
    Dunant NM; Senften M; Ballmer-Hofer K
    J Virol; 1996 Mar; 70(3):1323-30. PubMed ID: 8627648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
    Susa M; Rohner D; Bichsel S
    Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice.
    Stein PL; Vogel H; Soriano P
    Genes Dev; 1994 Sep; 8(17):1999-2007. PubMed ID: 7958873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.
    Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS
    Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.